Search results
Brain cancer in children is notoriously hard to treat – a new mRNA cancer vaccine triggers an attack...
The Conversation via Yahoo News· 10 hours agoCancer vaccines have gained much interest among scientists but face a number of hurdles. A new mRNA...
People amazed at 'wild' video of immune cell fighting a highly aggressive deadly cancer cell and...
UNILAD· 6 days agocell. According to the American Cancer Society, in 2022, there was an estimated 1.9 million new...
Finding a Master Immune System Controller | HHMI
Howard Hughes Medical Institute· 9 hours agoThe immune system is crucial for survival, enabling humans and other creatures to fend off the hordes of microbial invaders and other dangers that threaten ...
A New Weapon Against Cancer: Checkpoint Inhibitors, A Double-Edged Sword
Forbes· 3 days agoThis article joins a growing series on mono cancer treatments, including novel immunotherapies such...
Unlocking the immune system: cGAS-STING pathway offers new hope for cancer treatment
Medical Xpress· 1 day agoCancer immunotherapy, which leverages the body's immune system to target tumors, has emerged as a pivotal strategy in oncology. This paradigm shift from ...
Experimental vaccine targets portions of the flu virus that don't change
Medical Xpress· 7 hours agoInfluenza strains are referred to by a shorthand code, H5N1 for example, that describes which flavors of two particular surface proteins it carries. The H (sometimes HA), is hemagglutinin, a ...
Cancer cell–immune cell interactions can predict immunotherapy response
Medical Xpress· 2 days agoDr. Chan explained that over the past several decades, researchers have had a growing understanding...
First cancer jab trial finds they 'weaponise immunse system to attack tumours'
The US Sun· 10 hours agoA NEW mRNA cancer vaccine can reprogram the immune system to attack tumours within 48 hours, a study shows. The first-ever human clinical trial of four ...
Q&A: Harnessing the power of the immune system to combat cancer
Digital Journal· 13 hours agoRJ Tesi: INmune Bio was formed in 2015 as a private biotech company focused on harnessing the power...
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to...
Morningstar· 3 days agoRepertoire® Immune Medicines, a biotechnology company pioneering the discovery and development of programmable T cell targeted
